BCR–ABL1 transcript doubling time as a predictor for treatment‐free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase (Englisch)
- Neue Suche nach: Kim, Dennis Dong Hwan
- Neue Suche nach: Kim, Taehyung Simon
- Neue Suche nach: Atenafu, Eshetu G.
- Neue Suche nach: Novitzky Basso, Igor
- Neue Suche nach: Forrest, Donna
- Neue Suche nach: Bence‐Bruckler, Isabelle
- Neue Suche nach: Savoie, Lynn
- Neue Suche nach: Busque, Lambert
- Neue Suche nach: Keating, Mary‐Margaret
- Neue Suche nach: Delage, Robert
- Neue Suche nach: Xenocostas, Anargyros
- Neue Suche nach: Liew, Elena
- Neue Suche nach: Paulson, Kristjan
- Neue Suche nach: Stockley, Tracy
- Neue Suche nach: Laneuville, Pierre
- Neue Suche nach: Lipton, Jeffrey H.
- Neue Suche nach: Kamel‐Reid, Suzanne
- Neue Suche nach: Leber, Brian
- Neue Suche nach: Kim, Dennis Dong Hwan
- Neue Suche nach: Kim, Taehyung Simon
- Neue Suche nach: Atenafu, Eshetu G.
- Neue Suche nach: Novitzky Basso, Igor
- Neue Suche nach: Forrest, Donna
- Neue Suche nach: Bence‐Bruckler, Isabelle
- Neue Suche nach: Savoie, Lynn
- Neue Suche nach: Busque, Lambert
- Neue Suche nach: Keating, Mary‐Margaret
- Neue Suche nach: Delage, Robert
- Neue Suche nach: Xenocostas, Anargyros
- Neue Suche nach: Liew, Elena
- Neue Suche nach: Paulson, Kristjan
- Neue Suche nach: Stockley, Tracy
- Neue Suche nach: Laneuville, Pierre
- Neue Suche nach: Lipton, Jeffrey H.
- Neue Suche nach: Kamel‐Reid, Suzanne
- Neue Suche nach: Leber, Brian
In:
British Journal of Haematology
;
196
, 1
;
136-145
;
2022
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:BCR–ABL1 transcript doubling time as a predictor for treatment‐free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase
-
Beteiligte:Kim, Dennis Dong Hwan ( Autor:in ) / Kim, Taehyung Simon ( Autor:in ) / Atenafu, Eshetu G. ( Autor:in ) / Novitzky Basso, Igor ( Autor:in ) / Forrest, Donna ( Autor:in ) / Bence‐Bruckler, Isabelle ( Autor:in ) / Savoie, Lynn ( Autor:in ) / Busque, Lambert ( Autor:in ) / Keating, Mary‐Margaret ( Autor:in ) / Delage, Robert ( Autor:in )
-
Erschienen in:British Journal of Haematology ; 196, 1 ; 136-145
-
Verlag:
-
Erscheinungsdatum:01.01.2022
-
Format / Umfang:145 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 196, Ausgabe 1
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Issue Information| 2022
- 7
-
Acquired elliptocytosis in a patient with myelodysplastic syndrome harbouring a novel unbalanced whole‐arm translocation, der(14;20)(q10;p10)Manabe, Masahiro / Hagiwara, Yuuji / Asada, Reiko / Tanizawa, Nao / Nanno, Satoru / Koh, Ki‐Ryang et al. | 2022
- 8
-
Chronic myeloid leukaemia presenting with monocytosisPodvin, Benjamin / Goursaud, Laure / Roynard, Pauline / Nibourel, Olivier / Duployez, Nicolas / Fenwarth, Laurène et al. | 2022
- 9
-
Merozoites phagocytosed by neutrophils in Plasmodium falciparum malariaBarros Pinto, Marco P. / Melo Cristino, J. et al. | 2022
- 10
-
Unfolding the potential of anti‐programmed cell death protein 1 blockade in Hodgkin lymphoma – combination and personalisation?Bröckelmann, Paul J. et al. | 2022
- 13
-
Finding the best haematopoietic stem cell transplant regimen for GATA2 haploinsufficiency: how close are we?Connelly, James A. / Savani, Bipin N. et al. | 2022
- 15
-
Commentary: surviving sexism in bleeding disorders affecting womenSholzberg, Michelle / James, Paula D. et al. | 2022
- 17
-
Bridging the implementation gap in medication adherence. If you build it, will they come?Hankins, Jane S. / Klesges, Lisa M. et al. | 2022
- 19
-
Multiplex technologies for the assessment of minimal residual disease and low‐level mutation detection in leukaemia: mass spectrometry versus next‐generation sequencingShanmuganathan, Naranie / Branford, Susan et al. | 2022
- 31
-
Haemophagocytic lymphohistiocytosis and Epstein–Barr virus: a complex relationship with diverse origins, expression and outcomesEl‐Mallawany, Nader Kim / Curry, Choladda V. / Allen, Carl E. et al. | 2022
- 45
-
Pathogenesis, risk factors and therapeutic options for autoimmune haemolytic anaemia in the post‐transplant settingGabelli, Maria / Ademokun, Christine / Cooper, Nichola / Amrolia, Persis I. et al. | 2022
- 63
-
Saving lives through early diagnosis: the promise and role of point of care testing for sickle cell diseaseDexter, Daniel / McGann, Patrick T. et al. | 2022
- 70
-
Management of cardiovascular complications of bruton tyrosine kinase inhibitorsTang, Chloe Pek Sang / Lip, Gregory Y.H. / McCormack, Terry / Lyon, Alexander R. / Hillmen, Peter / Iyengar, Sunil / Martinez‐Calle, Nicolas / Parry‐Jones, Nilima / Patten, Piers E.M. / Schuh, Anna et al. | 2022
- 79
-
Clinical outcomes and the impact of prior oral anticoagulant use in patients with coronavirus disease 2019 admitted to hospitals in the UK — a multicentre observational studyArachchillage, Deepa J. / Rajakaruna, Indika / Odho, Zain / Crossette‐Thambiah, Christina / Nicolson, Phillip L. R. / Roberts, Lara N. / Allan, Caroline / Lewis, Sarah / Riat, Renu / Mounter, Philip et al. | 2022
- 95
-
COVID symptoms, testing, shielding impact on patient‐reported outcomes and early vaccine responses in individuals with multiple myelomaRamasamy, Karthik / Sadler, Ross / Jeans, Sally / Varghese, Sherin / Turner, Alison / Larham, Jemma / Gray, Nathanael / Barrett, Joe / Bowcock, Stella / Cook, Gordon et al. | 2022
- 99
-
Histopathological growth patterns in patients with advanced nodular lymphocyte‐predominant Hodgkin lymphoma treated within the randomized HD18 study: a report from the German Hodgkin Study GroupEichenauer, Dennis A. / Bühnen, Ina / Kreissl, Stefanie / Goergen, Helen / Fuchs, Michael / von Tresckow, Bastian / Rosenwald, Andreas / Klapper, Wolfram / Hansmann, Martin‐Leo / Möller, Peter et al. | 2022
- 105
-
Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxisPiedra, Katrina / Peterson, Tim / Tan, Carlyn / Orozco, Jennifer / Hultcrantz, Malin / Hassoun, Hani / Mailankody, Sham / Lesokhin, Alexander / Shah, Urvi / Lu, Sydney et al. | 2022
- 110
-
In male Hodgkin lymphoma patients, impaired fertility may be improved by non‐gonadotoxic therapyLaddaga, Filomena Emanuela / Masciopinto, Pierluigi / Nardelli, Claudia / Vacca, Margherita Patrizia / Masciandaro, Paola / Arcuti, Elena / Cicinelli, Ettore / Specchia, Giorgina / Musto, Pellegrino / Gaudio, Francesco et al. | 2022
- 116
-
9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trialGerhard‐Hartmann, Elena / Goergen, Helen / Bröckelmann, Paul J. / Mottok, Anja / Steinmüller, Tabea / Grund, Johanna / Zamò, Alberto / Ben‐Neriah, Susana / Sasse, Stephanie / Borchmann, Sven et al. | 2022
- 127
-
Combination of PD‐1 inhibitor with GVD (gemcitabine, vinorelbine, liposomal doxorubicin) versus GVD regimen as second‐line therapy for relapsed/refractory classical Hodgkin lymphomaZhang, Yu‐Chen / Wang, Jin‐Ni / Ma, Shu‐Yun / Cai, Jun / Su, Ning / Huang, Hui‐Qiang / Li, Zhi‐Ming / Xia, Zhong‐Jun / Huang, He / Liu, Pan‐Pan et al. | 2022
- 136
-
BCR–ABL1 transcript doubling time as a predictor for treatment‐free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phaseKim, Dennis Dong Hwan / Kim, Taehyung Simon / Atenafu, Eshetu G. / Novitzky Basso, Igor / Forrest, Donna / Bence‐Bruckler, Isabelle / Savoie, Lynn / Busque, Lambert / Keating, Mary‐Margaret / Delage, Robert et al. | 2022
- 146
-
Clinico‐biological features and outcome of patients with splenic marginal zone lymphoma with histological transformationBastidas‐Mora, Gabriela / Beà, Sílvia / Navarro, Alba / Gine, Eva / Costa, Dolors / Delgado, Julio / Baumann, Tycho / Magnano, Laura / Rivas‐Delgado, Alfredo / Villamor, Neus et al. | 2022
- 156
-
Immune signatures of bone marrow cells can independently predict prognosis in patients with myelodysplastic syndromeWang, Yu‐Hung / Lin, Chien‐Chin / Yao, Chi‐Yuan / Hsu, Chia‐Lang / Tsai, Cheng‐Hong / Hou, Hsin‐An / Chou, Wen‐Chien / Tien, Hwei‐Fang et al. | 2022
- 169
-
Donor source and post‐transplantation cyclophosphamide influence outcome in allogeneic stem cell transplantation for GATA2 deficiencyNichols‐Vinueza, Diana X. / Parta, Mark / Shah, Nirali N. / Cuellar‐Rodriguez, Jennifer M. / Bauer, Thomas R. Jr / West, Robert R. / Hsu, Amy P. / Calvo, Katherine R. / Steinberg, Seth M. / Notarangelo, Luigi D. et al. | 2022
- 179
-
Cerebral and skeletal muscle tissue oxygenation during exercise challenge in children and young adults with sickle cell anaemiaBarriteau, Christina M. / Chiu, Abraham / Rodeghier, Mark / Liem, Robert I. et al. | 2022
- 183
-
Alpha haemoglobin‐stabilising protein concentration in the red blood cells of patients with sickle cell anaemia with and without hydroxycarbamide treatmentVasseur, Corinne / Domingues‐Hamdi, Elisa / Pakdaman, Sadaf / Galactéros, Frédéric / Baudin‐Creuza, Véronique et al. | 2022
- 193
-
A randomised controlled provider‐blinded trial of community health workers in sickle cell anaemia: effects on haematologic variables and hydroxyurea adherenceSmith, Wally R. / McClish, Donna K. / Lottenberg, Richard / Sisler, India Y. / Sop, Daniel / Johnson, Shirley / Villella, Anthony / Liles, Darla / Yang, Elizabeth / Chen, Ian et al. | 2022
- 204
-
Clinical and genetic factors are associated with kidney complications in African children with sickle cell anaemiaAdebayo, Oyindamola Christiana / Betukumesu, DieuMerci Kabasele / Nkoy, Agathe Bikupe / Adesoji, Oluyomi Modupe / Ekulu, Pepe Mfutu / Van den Heuvel, Lambertus P. / Levtchenko, Elena N. / Labarque, Veerle et al. | 2022
- 215
-
Prevalence, burden and treatment effects of vaginal bleeding in women with (suspected) congenital platelet disorders throughout life: a cross‐sectional studyPunt, Marieke C. / Ruigrok, Nienke D. / Bloemenkamp, Kitty W. M. / Uitslager, Nanda / Urbanus, Rolf T. / Groot, Evelyn / Kremer Hovinga, Idske C. L. / Schutgens, Roger E. G. / van Galen, Karin P. M. / the Thrombocytopathy in the Netherlands (TiN) Study Group et al. | 2022
- 224
-
Platelet transfusion improves clot formation and platelet function in severely thrombocytopenic haematology patientsKarlström, Cecilia / Gryfelt, Gunilla / Schmied, Laurent / Meinke, Stephan / Höglund, Petter et al. | 2022
- 234
-
Activation of circulating platelets in vaccine‐induced thrombotic thrombocytopenia and its reversal by intravenous immunoglobulinMcFadyen, James D. / Sharma, Prerna / Moon, Mitchell J. / Noonan, Jonathan / Goodall, Elizabeth / Tran, Huyen A. / Peter, Karlheinz et al. | 2022
- 237
-
Long‐term efficacy and safety of chemotherapy‐free first‐line iodine‐131‐rituximab radioimmunotherapy of follicular lymphomaKesavan, Murali / Zammar, Ghassan / McQuillan, James T. / Macdonald, William B. G. / Turner, J. Harvey / McQuillan, Andrew D. et al. | 2022
- 241
-
Characterisation of two tumour cell populations in the small cell variant of anaplastic lymphoma kinase‐positive anaplastic large cell lymphomaNoguchi, Kazuhiro / Ikawa, Yasuhiro / Takenaka, Mika / Sakai, Yuta / Fujiki, Toshihiro / Kuroda, Rie / Wada, Taizo et al. | 2022
- 244
-
Submyeloablative total body irradiation‐based conditioning and allogeneic stem cell transplantation in high‐risk myeloma with early progression after up‐front autologous transplantationMai, Elias K. / Schmitt, Thomas / Radujkovic, Aleksandar / König, Laila / Goldschmidt, Hartmut / Ho, Anthony D. / Luft, Thomas / Müller‐Tidow, Carsten / Dreger, Peter / Hegenbart, Ute et al. | 2022
- 248
-
Response to mitogen‐activated protein kinase inhibition of neurodegeneration in Langerhans cell histiocytosis monitored by cerebrospinal fluid neurofilament light as a biomarker: a pilot studyHenter, Jan‐Inge / Kvedaraite, Egle / Martín Muñoz, Daniel / Cheng Munthe‐Kaas, Monica / Zeller, Bernward / Nystad, Tove A. / Björklund, Caroline / Donnér, Isabella / Lourda, Magda / Zetterberg, Henrik et al. | 2022
- e1
-
Monoclonal antibodies for the treatment of COVID‐19 in a patient with high‐risk acute leukaemiaSaultier, Paul / Ninove, Laetitia / Szepetowski, Sarah / Veneziano, Mathilde / Visentin, Sandrine / Barlogis, Vincent / Saba Villarroel, Paola Mariela / Amroun, Abdennour / Loosveld, Marie / de Lamballerie, Xavier et al. | 2022
- e3
-
Rivaroxaban for the treatment of superficial vein thrombosis, experience at King’s College HospitalClapham, Rachel E. / Speed, Victoria / Czuprynska, Julia / Gazes, Anna / Guppy, Simon / Patel, Raj K. / Rea, Catherine / Vadher, Bipin / Arya, Roopen / Roberts, Lara N. et al. | 2022
- e6
-
Strong expansion of normal CD19‐negative B‐cell precursors after the use of blinatumomab in the first‐line therapy of acute lymphoblastic leukaemia in childrenMikhailova, Ekaterina / Roumiantseva, Julia / Illarionova, Olga / Lagoyko, Svetlana / Miakova, Natalia / Zerkalenkova, Elena / Zharikova, Liudmila / Olshanskaya, Yulia / Novichkova, Galina / Maschan, Michael et al. | 2022
- e9
-
Extramedullary blast crisis in a chronic myeloid leukaemia patient after achieving a major molecular response with bosutinibNakajima, Rui / Matsuo, Takuji / Sumiyoshi, Ritsu / Saito, Sumiko / Yamamoto, Tadashi / Matsumoto, Kensuke / Akiyama, Nobu / Ooi, Jun / Ota, Yasunori / Shirafuji, Naoki et al. | 2022
- e11
-
Thrombotic thrombocytopenic purpura temporally associated with BNT162b2 vaccination in an adolescent successfully treated with caplacizumabKirpalani, Amrit / Garabon, Justin / Amos, Kiersten / Patel, Serina / Sharma, Ajay P / Ganesan, Saptharishi Lalgudi / Barton, Michelle / Cacciotti, Chantel / Leppington, Sarah / Bakovic, Linda et al. | 2022